One to two out of every 100 newborn babies are born with a Congenital Heart Defect (CHD), yet the exact cause remains unclear. Human geneticists at the University Medicine Oldenburg (Germany) have now ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new national ...

A daily multivitamin taken over two years slowed the pace of certain molecular aging markers in older adults, according to a ...

Tirzepatide, which is marketed as Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist that has ...

A genome-wide cfDNA methylation enrichment method (cfMeDIP-seq) enables response monitoring using plasma alone, avoiding ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Both optical genome mapping and long-read sequencing will be reflexed automatically to eligible cases where a qualified variant discovered through Baylor Genetics' WGS test may benefit from a deeper ...

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology ...

BACKGROUND: Aortic valve calcification increases leaflet stiffness and contributes to the development of calcific aortic valve disease. The molecular and cellular mechanisms underlying calcification ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:30 PM EDTCompany ParticipantsNicholas Keher ...